SleepLab-Laboratório de Estudo dos Distúrbios do Sono, Centro Médico BarraShopping, Rio de Janeiro, Brazil.
Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
J Clin Sleep Med. 2022 May 1;18(5):1271-1278. doi: 10.5664/jcsm.9842.
To assess whether nocturnal symptoms of insomnia influence the prevalence of obstructive sleep apnea (OSA) in a clinical referral cohort.
Insomnia was defined by the presence of 1 or more of the following complaints: difficulty initiating sleep, difficulty maintaining sleep, and/or early morning awakenings. OSA severity was based on an apnea-hypopnea index: ≥ 5.0 events/h (any OSA), ≥ 15.0 events/h (moderate/severe OSA), and ≥ 30 events/h (severe OSA). Multivariate logistic regression analysis was used to evaluate predictive factors for OSA diagnosis and severity.
Overall, 12,021 outpatients referred for polysomnography were grouped into 2 cohorts: without insomnia (58.2%) and with insomnia (41.8%). Individuals without insomnia had a higher prevalence of OSA than those with insomnia ( < .001, for all OSA severity levels). The presence of insomnia was negatively associated with diagnosis of any OSA (adjusted odds ratio: 0.852; 95% confidence interval: 0.769-0.944), moderate/severe OSA (adjusted odds ratio: 0.819; 95% confidence interval: 0.751-0.892), and severe OSA (adjusted odds ratio: 0.816; 95% confidence interval: 0.746-0.892). Moreover, the number of nocturnal symptoms of insomnia was associated with a lower likelihood of OSA, even when adjusted for other confounders such as sex, age, body mass index, neck circumference, excessive daytime sleepiness, hypertension, and type 2 diabetes mellitus.
In this present study that included a large sample of consecutive outpatients, there was an inverse relationship between the number of nocturnal symptoms of insomnia and OSA diagnosis.
Duarte RLM, Magalhães-da-Silveira FJ, Gozal D. Influence of nocturnal insomnia symptoms on obstructive sleep apnea diagnosis in a clinical referral cohort. . 2022;18(5):1271-1278.
评估失眠的夜间症状是否会影响临床转诊人群中阻塞性睡眠呼吸暂停(OSA)的患病率。
失眠的定义为存在以下 1 种或多种症状:入睡困难、睡眠维持困难和/或清晨早醒。OSA 严重程度基于呼吸暂停-低通气指数:≥ 5.0 次/小时(任何 OSA)、≥ 15.0 次/小时(中重度/重度 OSA)和≥ 30.0 次/小时(重度 OSA)。多变量逻辑回归分析用于评估 OSA 诊断和严重程度的预测因素。
总体而言,12021 名因多导睡眠图检查而转诊的门诊患者被分为 2 个队列:无失眠(58.2%)和有失眠(41.8%)。无失眠的患者比有失眠的患者更常见 OSA(<.001,所有 OSA 严重程度水平)。存在失眠与任何 OSA(调整后的优势比:0.852;95%置信区间:0.769-0.944)、中重度 OSA(调整后的优势比:0.819;95%置信区间:0.751-0.892)和重度 OSA(调整后的优势比:0.816;95%置信区间:0.746-0.892)的诊断呈负相关。此外,即使在调整了性别、年龄、体重指数、颈围、白天过度嗜睡、高血压和 2 型糖尿病等其他混杂因素后,失眠的夜间症状数量也与 OSA 的可能性降低相关。
在这项包括大量连续门诊患者的研究中,夜间失眠症状的数量与 OSA 诊断呈负相关。
Duarte RLM, Magalhães-da-Silveira FJ, Gozal D. 夜间失眠症状对临床转诊人群阻塞性睡眠呼吸暂停诊断的影响。. 2022;18(5):1271-1278.